鸿茅药酒品牌怎么样 申请店铺

我要投票 鸿茅药酒在保健酒行业中的票数:650 更新时间:2025-12-14
鸿茅药酒是哪个国家的品牌?「鸿茅药酒」是内蒙古鸿茅国药股份有限公司旗下著名品牌。该品牌发源于内蒙古,由创始人鲍洪升在2002期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力鸿茅药酒品牌出海!将品牌入驻外推网,定制鸿茅药酒品牌推广信息,可以显著提高鸿茅药酒产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

鸿茅药酒怎么样

内蒙古鸿茅药业有限责任公司成立于2002年,其前身为内蒙古凉城县鸿茅酒厂。公司现有职工300余名,总资产超过2亿,生产基地占地280余亩,拥有药酒、保健酒等多个品种。

公司主营产品“鸿茅药酒”,始创于1739年(清乾隆四年),距今已经有近三百年的历史。曾作为宫廷贡酒,被封为皇室养生益寿的御用圣品,传承数百年药用历史,成为中华医药的瑰宝,并入选国家“非物质文化遗产名录”。

2011年,中华人民共和国商务部授予鸿茅为“中华老字号”;2011年,国家工商行政管理总局认定鸿茅为“驰名保护”;2014年“鸿茅药酒配制技艺”入选国务院批准文化部确定的《第四批非物质文化遗产代表性项目名录》。

新一代鸿茅人谨遵“良药济世,精工取繁”的百年祖训,结合传统“八步古法酿造工艺”和现代高科技萃取技术,创新开发出符合GMP标准的现代化工艺—20级精制法,不断提升药酒的品质,从源头上保证消费者的权益。

“使命民族企业,成就中华瑰宝”是鸿茅药业的企业发展理念,以文化为先导,以品质为核心,鸿茅药业坚守“仁、道、信、义、至善”的核心价值观,全面提升企业的新技艺研发能力,推动创新实效的企业运营模式,通过持续的品牌建设和创新营销,践行“百年鸿茅”的企业目标,做中医药文化的传播者。

新时期的鸿茅人正意气奋发地投身搏击于中国的经济大潮,依托于健康中国的发展机遇,以更加成就稳健的姿态去迎接这个神圣而艰巨的挑战,续写“百年鸿茅”品牌更辉煌的未来!

Inner Mongolia Hongmao Pharmaceutical Co., Ltd. was founded in 2002, its predecessor is Inner Mongolia Liangcheng Hongmao distillery. The company has more than 300 employees, a total assets of more than 200 million, a production base covering an area of more than 280 mu, with a variety of medicine wine, health wine and so on. The company's main product, "Hongmao medicinal wine", was founded in 1739 (the fourth year of Qianlong in the Qing Dynasty). It has a history of nearly 300 years. As a royal tribute wine, it was awarded as a Royal Saint for health preservation and longevity, inheriting hundreds of years of medicinal history, becoming a treasure of Chinese medicine and listed in the national intangible cultural heritage list. In 2011, the Ministry of Commerce of the people's Republic of China Awarded Hongmao as the "time-honored brand of China"; in 2011, the State Administration for Industry and Commerce recognized Hongmao as "well-known protection"; in 2014, "Hongmao liquor preparation technology" was selected into the "fourth batch of Intangible Cultural Heritage Representative project list" approved by the Ministry of culture. A new generation of Hongmao people, following the centenary motto of "good medicine for the world, precision work for the complex", combined with the traditional "eight step ancient brewing process" and modern high-tech extraction technology, have innovated and developed a modern process - 20 level refining process that meets the GMP standard, constantly improving the quality of medicinal wine, and ensuring the rights and interests of consumers from the source. "Mission of national enterprises, achievement of Chinese treasures" is Hongmao pharmaceutical's enterprise development concept, taking culture as the guide, quality as the core, Hongmao pharmaceutical adheres to the core values of "benevolence, Taoism, faith, righteousness, and supreme goodness", comprehensively improves the enterprise's new technology research and development ability, promotes the innovative and effective enterprise operation mode, and practices "one hundred years" through continuous brand building and innovative marketing Hongmao "aims to be a disseminator of traditional Chinese medicine culture. In the new era, Hongmao people are devoting themselves to the economic tide of China, relying on the development opportunity of healthy China, meeting this sacred and arduous challenge with a more stable attitude of achievement, and continuing to write a more brilliant future of "Hongmao" brand!

本文链接: https://brand.waitui.com/331f518f1.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

2025年人工智能核心产业规模有望破万亿元

12月14日,从中国信息通信研究院了解到,今年以来,我国人工智能产业呈加速发展态势,2025年人工智能核心产业规模有望突破万亿元。数据显示,今年以来,生产制造环节的大模型应用增长显著,应用案例占比由去年的19.9%增长至25.9%,带动人工智能产业规模快速增长。(央视新闻)

8分钟前

近一周逾260家公司获机构调研 中科曙光和海光信息获调研数最多

近一周获得机构调研的个股有260多只,中科曙光和海光信息调研机构数最多。中科曙光和海光信息近一周有341家机构调研。中科曙光方面表示,尽管重组终止,但海光与曙光仍将在保持上市公司独立性基础上深化协同。安克创新、伟创电气等个股也均获得逾百家机构调研。从市场表现来看,近一周机构调研股月内平均上涨近1%。超捷股份、霍莱沃、斯瑞新材、博盈特焊、华菱线缆等个股均涨逾20%。(人民财讯)

8分钟前

调查:美联储明年1月降息25个基点的概率为24.4%

12月14日,据CME“美联储观察”:美联储2026年1月降息25个基点的概率为24.4%,维持利率不变的概率为75.69%。美联储到明年3月累计降息25个基点的概率为41.4%,维持利率不变的概率为50.5%,累计降息50个基点的概率为8.1%。(界面新闻)

8分钟前

万科三个展期议案均未获通过 仍有5个工作日宽限期

12月13日公告显示,万科“22万科MTN004”持有人会议三项展期议案均未获有效通过,核心展期规则均为展期一年且期间不付本息,差异在增信安排。议案一未设增信,无人同意;议案二增信加调整本息兑付,获83.40%同意;议案三仅一票同意。万科还有5个工作日宽限期谈判。(新浪财经)

8分钟前

2030年我国天然气产量将达3000亿立方米

《中国油气行业“十四五”发展成就报告》显示,中国正加速迈向现代油气产业发展新阶段,能源结构日趋多元均衡,2030年我国天然气产量将达到3000亿立方米。报告显示,“十四五”期间我国累计新增探明地质储量石油70亿吨、天然气7万亿立方米,分别较“十三五”增长约43%、40%,油气产量创历史新高。(央视新闻)

8分钟前

本页详细列出关于鸿茅药酒的品牌信息,含品牌所属公司介绍,鸿茅药酒所处行业的品牌地位及优势。
咨询